The DLH Foundation

The DLH Foundation is committed to advancing a cure for CDH1 mutation carriers through innovative chemo prevention research.

parry-and-thad.webp
volunteer_activism_24dp_FFFFFF_FILL0_wght400_GRAD0_opsz24
$200k+ USD

Grants distributed since 2023.

note_stack_24dp_FFFFFF_FILL0_wght400_GRAD0_opsz24

112 Grants

Supported since the beginning in 2015.

language_24dp_FFFFFF_FILL0_wght400_GRAD0_opsz24

8+ Studies and Trials

Impacted by our work.

WHO WE ARE

The DLH Foundation was created by a family personally affected by the CDH1 gene mutation across generations. Guided by experience, we are dedicated to supporting research and offering hope to those facing hereditary diffuse gastric cancer.

LEARN MORE →

march-1-beaker-computer.webp
IN THE SPOTLIGHT:

The Save Our Stomachs Campaign.

Building an endowment fund supporting sustained Hereditary Diffuse Gastric Cancer syndrome research.

LEARN MORE →

RECENT GRANTS

Dr. Jeremy L. Davis

Healthcare

$30,000 USD donated to CDH1 related clinical trials.

Professor Parry Guilford, MSc, PhD

Healthcare

$180,000 USD donated to The University of Otago Foundation for chemotherapy prevention drug research.

Dr. Yanghee Woo

Healthcare

$49,950 USD donated to City of Hope for HIPEC trials.